NEW YORK (GenomeWeb) – Commercial laboratories offering cell-free DNA-based noninvasive prenatal testing (NIPT) in the US do not follow all recommendations put forward by the American College of Medical Genetics and Genomics in 2016, a new study has found. According to the authors, this may lead to confusion and improper counseling.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.